These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11821173)

  • 21. Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species.
    Johnson DM; Biedenbach DJ; Beach ML; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 2000 Jun; 37(2):99-105. PubMed ID: 10863104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
    Pfaller MA; Farrell DJ; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of cefditoren against a special collection of clinical isolates of Streptococcus pneumoniae from Hungary.
    Nagy E; Marton A; Hajdú E
    Acta Microbiol Immunol Hung; 2003; 50(2-3):119-24. PubMed ID: 12894483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.
    Jones RN; Biedenbach DJ; Croco MA; Barrett MS
    Diagn Microbiol Infect Dis; 1998 Aug; 31(4):573-8. PubMed ID: 9764398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United States.
    Biedenbach DJ; Jones RN; Fritsche TR
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):240-4. PubMed ID: 18353594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Feb; 40(2):481-4. PubMed ID: 8834904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group study.
    Fogarty CM; Cyganowski M; Palo WA; Hom RC; Craig WA
    Clin Ther; 2002 Nov; 24(11):1854-70. PubMed ID: 12501879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro Activity of Cefditoren against Middle Ear Fluid Isolates from Costa Rican Children with Otitis Media.
    Ulloa C; Guevara S; Soley C; Abdelnour A; Arguedas A
    Chemotherapy; 2014; 60(4):211-8. PubMed ID: 25871785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of cefditoren: antimicrobial efficacy against major respiratory pathogens from Asian countries.
    Lee MY; Ko KS; Oh WS; Park S; Lee JY; Baek JY; Suh JY; Peck KR; Lee NY; Song JH
    Int J Antimicrob Agents; 2006 Jul; 28(1):14-8. PubMed ID: 16777383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of cefditoren against beta-lactamase-positive and -negative Haemophilus influenzae and Moraxella catarrhalis.
    Karlowsky JA; Critchley IA; Draghi DC; Jones ME; Thornsberry C; Sahm DF
    Diagn Microbiol Infect Dis; 2002 Jan; 42(1):53-8. PubMed ID: 11821172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefditoren activity against nearly 1000 non-fastidious bacterial isolates and the development of in vitro susceptibility test methods.
    Jones RN; Biedenbach DJ; Johnson DM
    Diagn Microbiol Infect Dis; 2000 Jun; 37(2):143-6. PubMed ID: 10863109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
    McGee L; Biek D; Ge Y; Klugman M; du Plessis M; Smith AM; Beall B; Whitney CG; Klugman KP
    Antimicrob Agents Chemother; 2009 Feb; 53(2):552-6. PubMed ID: 19015339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic options for pneumococcal pneumonia in Turkey.
    Oncu S; Erdem H; Pahsa A
    Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics.
    Kaplan SL; Mason EO; Barson WJ; Tan TQ; Schutze GE; Bradley JS; Givner LB; Kim KS; Yogev R; Wald ER
    Pediatr Infect Dis J; 2001 Apr; 20(4):392-6. PubMed ID: 11332663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents.
    Pankuch GA; Davies TA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2002 Jan; 46(1):42-6. PubMed ID: 11751109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro study of the post-antibiotic effect and the bactericidal activity of Cefditoren and ten other oral antimicrobial agents against upper and lower respiratory tract pathogens.
    Dubois J; St-Pierre C
    Diagn Microbiol Infect Dis; 2000 Jul; 37(3):187-93. PubMed ID: 10904192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of agar dilution, microdilution, E-test, and disk diffusion methods for testing activity of cefditoren against Streptococcus pneumoniae.
    Kelly LM; Jacobs MR; Appelbaum PC
    J Clin Microbiol; 1999 Oct; 37(10):3296-9. PubMed ID: 10488195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-lactam activity against penicillin-resistant Streptococcus pneumoniae strains exhibiting higher amoxicillin versus penicillin minimum inhibitory concentration values: an in vitro pharmacodynamic simulation.
    Sevillano D; Aguilar L; Alou L; Giménez MJ; González N; Echeverría O; Torrico M; Valdes L; Coronel P; Prieto J
    Chemotherapy; 2008; 54(2):84-90. PubMed ID: 18303256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative activity of twelve beta-lactam drugs tested against penicillin-resistant Streptococcus pneumoniae from five medical centers: effects of serum protein and capsular material on potency and spectrum as measured by reference tests.
    Johnson DM; Doern GV; Haugen TA; Hindler J; Washington JA; Jones RN
    Diagn Microbiol Infect Dis; 1996 Jul; 25(3):137-41. PubMed ID: 8902410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.